Yong Zhang

Bispecific antibodies have drawn considerate research interests for therapeutic development. Numerous genetic and chemical methods are established to produce bispecific antibodies with varied formats. This protocol describes a novel approach to the synthesis of bispecific antibodies by utilizing chemically functionalized poly‐ADP‐ribose polymers derived from post‐translational poly‐ADP‐ribosylation. Basic Protocol 1 includes experimental procedures for expressing and purifying recombinant full‐length human poly‐ADP‐ribose polymerase 1 (PARP1) as well as monoclonal antibodies targeting T‐cell CD3 and breast cancer tumor‐associated human epidermal growth factor receptor 2 (HER2) molecules. Basic Protocol 2 details methods for enzymatic preparation of functionalized poly‐ADP‐ribose polymers by PARP1 and chemical conjugation of antibody molecules for bispecific antibody production. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Expression and purification of PARP1 and antibodies Basic Protocol 2 : PARP1 auto‐modification and antibody conjugation